发明名称 Combination Therapy for Treatment of Inflammatory Demyelinating Disease
摘要 Provided herein include combination therapies for the treatment of neurological inflammatory diseases, such as, for example, demyelinating autoimmune diseases, such as multiple sclerosis and neuromyelitis optica, etc. In various aspects and embodiments, the methods may include administering to a patient an effective dose of an inhibitor of an angiotensin-converting enzyme (ACE) in combination with one or more second compounds, In one aspect, provided is a method of treating a demyelinating autoimmune disease (such as multiple sclerosis) that includes administering to a patient an effective dose of an inhibitor of an angiotensin-converting enzyme (ACE) in combination with one or more compounds selected from the group consisting of a cytokine, a vitamin B, dimethyl fumarate (DMF, also referred to as BG-12) and fingolimod (Gilenya).
申请公布号 US2014308244(A1) 申请公布日期 2014.10.16
申请号 US201214236877 申请日期 2012.08.07
申请人 Steinman Lawrence;Ho Peggy Pui-Kay 发明人 Steinman Lawrence;Ho Peggy Pui-Kay
分类号 A61K31/40;A61K31/137;A61K31/225;A61K38/21;A61K31/714 主分类号 A61K31/40
代理机构 代理人
主权项 1. (canceled)
地址 Stanford CA US